Cancer-test firm reports profit growth

FORT MYERS — NeoGenomics reported revenues and profits grew as it benefited from an acquisition it made last year.

NeoGenomics reported net income of $1.05 million on revenues of $25 million in the fourth quarter ending Dec. 31. That compares with net income of $857,000 on revenues of $18.3 million in the fourth quarter of 2013.

NeoGenomics acquired California-based PathLogic in July, a provider of specialized anatomic pathology services, for $6 million. The company says the acquisition accounted for 13% of the revenue growth in the fourth quarter.